Topical nifedipine with lidocaine ointment vs. active control for treatment of chronic anal fissure: Results of a prospective, randomized, double-blind study

Diseases of the Colon and Rectum

Volumn 45, Issue 11, 2002, Pages 1468-1475

  Perrotti, Pasquale ^a   Bove, Antonio ^a   Antropoli, Carmine ^a   Molino, Domenico ^a   Antropoli, Massimo ^a   Balzano, Antonio ^a   De Stefano, Guglielmo ^a   Attena, Francesco ^a  

^a NONE   (Italy)

Author keywords

Anal fissure; Chemical sphincterotomy; Nifedipine; Treatment

Indexed keywords

HYDROCORTISONE; LIDOCAINE; NIFEDIPINE;

ADOLESCENT; ADULT; AGED; ANORECTAL PRESSURE; ANOSCOPY; ANUS FISSURE; ARTICLE; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; MANOMETRY; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SIDE EFFECT; SPHINCTEROTOMY;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; CHRONIC DISEASE; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; FISSURE IN ANO; HUMANS; HYDROCORTISONE; LIDOCAINE; MALE; MANOMETRY; MIDDLE AGED; NIFEDIPINE; PROSPECTIVE STUDIES; RECURRENCE; TREATMENT OUTCOME;

EID: 0036848962     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10350-004-6452-1     Document Type: Article

References (45)

1. Lund JN, Scholefield JH. Aetiology and treatment of anal fissure. Br J Surg 1996;83:1335-44.
2. Farouk R, Duthie GS, MacGregor AB, Bartolo DC. Sustained internal sphincter hypertonia in patients with chronic anal fissure. Dis Colon Rectum 1994;37:424-9.
3. Schouten WR, Briel JW, Auwerda JJ, De Graaf EJ. Ischaemic nature of anal fissure. Br J Surg 1996;83:63-5.
4. Oh C, Divino CM, Steinhagen RM. Anal fissure: 20-Year experience. Dis Colon Rectum 1995;38:378-82.
5. Jensen SL, Lund F, Nielsen OV, Tange G. Lateral subcutaneous sphincterotomy versus anal dilatation in the treatment of fissure in ano: A prospective randomized study. Br Med J 1984;289:528-30.
6. Nyam DC, Pemberton JH. Long-term results of lateral internal sphincterotomy for chronic anal fissure with particular reference to incidence of fecal incontinence. Dis Colon Rectum 1999;42:1306-10.
7. Jost WH. One hundred cases of anal fissure treated with botulin toxin: Early and long-term results. Dis Colon Rectum 1997;40:1029-32.
8. Maria G, Cassetta E, Gui D, Brisinda G, Bentivoglio AR, Albanese A. A comparison of botulinum toxin and saline for the treatment of chronic anal fissure. N Engl J Med 1998;338:217-20.
9. Schouten WR, Briel JW, Boerma MO, Auwerda JJ, Wilms EB, Graatsma BH. Pathophysiological aspects and clinical outcome of intra-anal application of isosorbide dinitrate in patients with chronic anal fissure. Gut 1996;39:465-9.
10. Lund JN, Scholefield JH. A randomized, prospective, double-blind, placebo-controlled trial of glyceryl trinitrate ointment in treatment of anal fissure. Lancet 1997;349:11-4.
11. Kennedy ML, Sowter S, Nguyen H, Lubowski DZ. Glyceryl trinitrate ointment for the treatment of chronic anal fissure: Results of a placebo-controlled trial and long-term follow-up. Dis Colon Rectum 1999;42:1000-6.
12. Carapeti EA, Kamm MA, Phillips RK. Topical diltiazem and betanachol decrease anal sphincter pressure and heal anal fissures without side effects. Dis Colon Rectum 2000;43:1359-62.
13. Antropoli C, Perrotti P, Rubino M, et al. Nifedipine for local use in conservative treatment of anal fissures: Preliminary results of a multicenter study. Dis Colon Rectum 1999;42:1011-5.
14. Cook TA, Smilgin Humphreys MM, Mortensen NJ. Oral nifedipine reduces resting anal pressure and heals chronic anal fissures. Br J Surg 1999;86:1269-73.
15. Altomare DF, Rinaldi M, Milito G, et al. Glyceryl trinitrate for chronic anal fissure - Healing or headache? Results of a multicenter, randomized, placebo-controlled, double-blind trial. Dis Colon Rectum 2000;43:174-81.
16. Carapeti EA, Kamm MA, McDonald PJ, Chadwick SJ, Melville D, Phillips RK. Randomized controlled trial shows that glyceryl trinitrate heals anal fissures, higher doses are not more effective, and there is a high recurrence rate. Gut 1999;44:727-30.
17. Carapeti EA, Kamm MA, Evans BK, Phillips RK. Topical diltiazem and bethanechol decrease anal sphincter pressure without side effects. Gut 1999;45:719-22.
18. Knight JS, Birks M, Farouk R. Topical diltiazem ointment in the treatment of chronic anal fissure Br J Surg 2001;88:553-6.
19. Perrotti P, Antropoli C, Noschese G, et al. Topical nifedipine for conservative treatment of acute haemorrhoidal thrombosis. Colorectal Dis 2000;2:18-21.
20. Perrotti P, Antropoli C, Molino D, De Stefano G, Antropoli M. Conservative treatment of acute thrombosed external hemorrhoids with topical nifedipine. Dis Colon Rectum 2001;44:405-9.
21. McDonald P, Driscoll AM, Nicholls RJ. The anal dilator in the conservative management of acute anal fissures. Br J Surg 1983;70:25-6.
22. Jensen SI. Treatment of first episodes of acute anal fissure: Prospective randomized study of lignocaine ointment versus hydrocortisone ointment or warm sitz baths plus bran. Br Med J 1986;292:1167-9.
23. Khubchandani IT, Reed JF. Sequelae of internal sphincterotomy for chronic anal fissure in ano. Br J Surg 1989;76:431-4.
24. Brisinda G, Maria G, Bentivoglio AR, Cassetta, E, Gui D, Albanese A. A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure. N Engl J Med 1999;341:65-9.
25. Jost WH, Schanne S, Militz H, Schimrigk K. Perianal thrombosis following injection therapy into the external anal sphincter using botulin toxin [letter]. Dis Colon Rectum 1995;38:781.
26. Richard CS, Gregoire R, Plewes EA, et al. Internal sphincterotomy is superior to topical nitroglycerin in the treatment of chronic anal fissure: Results of a randomized, controlled trial by the Canadian Colorectal Surgical Trials Group. Dis Colon Rectum 2000;43:1048-58.
27. Watson SJ, Kamm MA, Nicholls RJ, Phillips RK. Topical glyceryl trinitrate in the treatment of chronic anal fissure. Br J Surg 1996;83:771-5.
28. Hyman NH, Cataldo PA. Nitroglycerin ointinent for anal fissures: Effective treatment or just a headache? Dis Colon Rectum 1999;42:383-5.
29. Loder, PB, Kamm MA, Nicholls RJ, Phillips RK. Reversible chemical sphincterotomy by local application of glyceryl trinitrate. Br J Surg 1994;81:1386-9.
30. Gorfine SR. Treatment of benign anal disease with topical nitroglycerin. Dis Colon Rectum 1995;38:453-7.
31. Bacher H, Mischinger H-J, Werkgartner G, et al. Local nitroglycerin for treatment of anal fissures: An alternative to lateral sphincterotomy? Dis Colon Rectum 1997;40:840-5.
32. Triggle DJ. Calcium, calcium channels, and calcium channel antagonists. Can J Physiol Pharmacol 1990;68:1474-81
33. Jonard P, Essamri B. Diltiazem and internal anal sphincter [letter]. Lancet 1987;1:754.
34. Chrysos E, Xynos E, Tzovaras G, Zoras OJ, Tsiaoussis J, Vassilakis SJ. Effect of nifedipine on rectoanal motility. Dis Colon Rectum 1996;39:212-6.
35. Cook TA, Brading AF, Mortensen NJ. Differences in contractile properties of anorectal smooth muscle and the effects of calcium channel blockade. Br J Surg 1999;86:70-5.
36. Cook TA, Brading AF, Mortensen NJ. Effects of nifedipine on anorectal smooth muscle in vitro. Dis Colon Rectum 1999;42:782-7.
37. Jonas M, Neal KR, Abercrombie JF, Scholefield JH. A randomized trial of oral vs. topical diltiazem for chronic anal fissures. Dis Colon Rectum 2001;44:1074-8.
38. Opie LH. Calcium channel antagonists in the treatment of coronary artery disease: Fundamental pharmacological properties relevant to clinical use. Prog Cardiovasc Dis 1996;38:273-90.
39. Katz AM, Hager WD, Messineo FC, Pappano AJ. Cellular actions and pharmacology of the calcium-channel blockers drugs. Am J Med 1984;77:2-10.
40. Carts NJ, Moran B, Johnson CD. Anorectal physiology measurements are of no value in clinical practice. True or false? Ann R Coll Surg Engl 1994;76:276-80.
41. Katoh N, Hirano S, Kishimoto S, Yasuno H. Calcium channel blockers suppress the contact hypersensitivity reaction (CHR) by inhibiting antigen transport and presentation by epidermal Langerhans cells in mice. Clin Exp Immunol 1997;108:302-8.
42. Fleischmann JD, Huntley HN, Shingleton WB, Wentworth DB. Clinical and immunological response to nifedipine for the treatment of interstitial cystitis. J Urol 1991;146:1235-9.
43. Brown AC, Sumfest JM, Rozwadowski JV. Histopathology of the internal anal sphincter in chronic anal fissure. Dis Colon Rectum 1989;32:680-3.
44. Oshiro H, Kobayashi I, Kim D, Takenaka H, Hobson RW II, Duran WN. L-type calcium channel blockers modulate the microvascular hyperpermeability induced by platelet-activating factor in vivo. J Vasc Surg 1995;22:732-9.
45. Landau AJ, Eberhardt RT, Frishman WH. Intranasal delivery of cardiovascular agents: An innovative approach to cardiovascular pharmacotherapy. Am Heart J 1994;127:1594-99.